NLP On Demand offers oncology healthcare professionals a powerful tool to extract, interpret, and gain valuable insight from clinical data.
Tampa, Florida, March 18, 2020 / GlobeNewswire—Cancer informatics and digital pathology solution provider Inspirata AI today unveiled its new cancer and clinical data extraction software service, NLP On Demand. Leveraging the power of artificial intelligence (AI) and natural language processing (NLP), the software standardizes patient data from clinical reports, identifies critical cancer information, determines the relevant context, and provides expert interpretation.
NLP On Demand offers scalable support to users, irrespective of how small or large their abstraction needs may be. Being completely cloud-based, the service can be used on a project basis to accommodate a range of task sizes, from small-scale research projects to full enterprise analytics.
“It was our goal to create a product that allows the capabilities of AI and NLP to be applied to cancer and clinical data extraction projects of all sizes. We offer a service tier for every budget and every project size so we can easily tailor our solution to a wide range of tasks,” said Trevor Heritage, Senior Vice President of Cancer Informatics.
The software offers over 99% accuracy to cancer case finding, while removing the tedious labor associated with manually extracting clinical data and increasing medical insight gained from clinical reports. The technology powering the NLP On Demand solution is already being utilized by the National Cancer Institute’s SEER Program, as well as various major healthcare institutions in the United States, Canada, and Australia.
Inspirata AI is currently offering a 100% risk free trial of NLP On Demand – click here for more information.
About Inspirata AI, Inc.
Using our native AI platform that is specifically optimized for oncology, Inspirata AI helps cancer programs identify reportable cancer cases in real time, directly from source documents from clinical systems including AP-LIS, Radiology and HER. Using our end-to-end cancer registry workflow automation solution, healthcare organizations can significantly improve their cancer data casefinding, data abstraction, reporting and data analytics in a single platform thus reducing manual burden, and gain earlier visibility into patients clinical data across their cancer care continuum.
Delivering 99% accuracy and actionable oncology intelligence, Inspirata AI transforms cancer registry operations from a traditional cost center into a strategic asset that can support oncology service line revenue growth, patient retention, accreditation readiness, research initiatives, and informed clinical and business decision-making. Trusted by many large healthcare organizations nationwide, Inspirata AI empowers cancer programs to maximize the value of their oncology data and remove duplicate data entry, enabling the service line to identify more patients quickly, retain more patients within their network, and improve patient outcomes across their cancer care journey.
Inspirata AI Contact:
Emil Mladenov, Vice President of Corporate and Digital Marketing
E-mail: emladenov@inspirata.com | Tel: +1-813-467-7616
